Sanjeev Satyal
Corporate Officer/Principal chez MONTEREY INNOVATION ACQUISITION CORP.
Postes actifs de Sanjeev Satyal
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MONTEREY INNOVATION ACQUISITION CORP. | Corporate Officer/Principal | 09/03/2023 | - |
| Directeur Général | 01/04/2021 | 09/03/2023 |
Historique de carrière de Sanjeev Satyal
Anciens postes connus de Sanjeev Satyal
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
pH Pharma Co., Ltd.
 pH Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology pH Pharma Co. Ltd. engages in the developing and manufacturing of bio-pharmaceuticals. Its products include php-303, php-201, ab-101, nuvesse, alpine and torpedo products. The company was founded by Ho Young Huh on September 22, 2015 and is headquartered in Seoul, South Korea. | Directeur Général | 01/01/2015 | 01/02/2021 |
| Directeur Technique/Scientifique/R&D | 01/01/2015 | 01/02/2021 | |
| ONCOMED PHARMACEUTICALS INC | Corporate Officer/Principal | - | - |
StemPar Sciences, Inc.
 StemPar Sciences, Inc. Medical/Nursing ServicesHealth Services StemPar Sciences, Inc. develops cancer drugs treatments. It provides cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy/radiation induced DNA damage. The company was founded by Hoyoung Huh and Mircea Florin Mihaescu in 2012 and is headquartered in Mill Valley, CA. | Directeur Technique/Scientifique/R&D | - | - |
| Stemguard Therapeutics, Inc. | Corporate Officer/Principal | - | - |
Formation de Sanjeev Satyal
| Northwestern University | Doctorate Degree |
| University of Pune | Graduate Degree |
| St. Xavier's College | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Inde | 3 |
| Corée du Sud | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
StemPar Sciences, Inc.
StemPar Sciences, Inc. Medical/Nursing ServicesHealth Services StemPar Sciences, Inc. develops cancer drugs treatments. It provides cancer drugs that attack solid tumors by simultaneously disrupting their source of energy and their ability to repair chemotherapy/radiation induced DNA damage. The company was founded by Hoyoung Huh and Mircea Florin Mihaescu in 2012 and is headquartered in Mill Valley, CA. | Health Services |
pH Pharma Co., Ltd.
pH Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology pH Pharma Co. Ltd. engages in the developing and manufacturing of bio-pharmaceuticals. Its products include php-303, php-201, ab-101, nuvesse, alpine and torpedo products. The company was founded by Ho Young Huh on September 22, 2015 and is headquartered in Seoul, South Korea. | Health Technology |
Monterey Innovation Acquisition Corp.
 Monterey Innovation Acquisition Corp. Financial ConglomeratesFinance Monterey Innovation Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 23, 2020 and is headquartered in New York, NY. | Finance |
| Stemguard Therapeutics, Inc. |
- Bourse
- Insiders
- Sanjeev Satyal
- Expérience